• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

区分预测性基因检测与万灵药:监管、责任与错失的机遇。

Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.

作者信息

Malinowski M J

机构信息

Widener University School of Law, USA.

出版信息

Jurimetrics. 2000 Fall;41(1):23-52.

PMID:15744897
Abstract

This article explores the extent to which completion of maps of the human genome, coupled with the introduction of technology that will accelerate the identification of gene and protein function, have introduced immeasurable potential to advance life science and health care through genetic profiling. In light of definitional uncertainty, the regulatory and legal environment surrounding predictive genetic testing threatens to impede clinical utilization of genetic profiling technologies that could significantly improve human health. Especially given that genetic testing technologies have been stigmatized in the public and medical community, they must enter the marketplace with a regulatory framework that assures safety, efficacy, and market responsibility.

摘要

本文探讨了人类基因组图谱的完成,以及加速基因和蛋白质功能鉴定的技术的引入,在多大程度上通过基因轮廓分析为推进生命科学和医疗保健带来了不可估量的潜力。鉴于定义的不确定性,围绕预测性基因检测的监管和法律环境可能会阻碍基因轮廓分析技术的临床应用,虽然这些技术能够显著改善人类健康。特别是考虑到基因检测技术在公众和医学界已被污名化,它们必须在一个确保安全、有效和市场责任的监管框架下进入市场。

相似文献

1
Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.区分预测性基因检测与万灵药:监管、责任与错失的机遇。
Jurimetrics. 2000 Fall;41(1):23-52.
2
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.基因检测服务的商业化:美国食品药品监督管理局、市场力量与生物塔罗牌
Tulane Law Rev. 1997 Mar;71(4):1211-312.
3
A conceptual framework for genetic policy: comparing the medical, public health, and fundamental rights models.遗传政策的概念框架:比较医学、公共卫生和基本权利模式。
Wash Univ Law Q. 2001;79(152):221-85.
4
Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.药物基因组学的监管视角:关于美国食品药品监督管理局面临的关键问题的文献综述
Med Care Res Rev. 2006 Jun;63(3):301-26. doi: 10.1177/1077558706287020.
5
Oversight of US genetic testing laboratories.美国基因检测实验室的监管
Nat Biotechnol. 2006 Sep;24(9):1083-90. doi: 10.1038/nbt0906-1083.
6
Science and regulation. Regulating direct-to-consumer personal genome testing.科学与监管。规范面向消费者的个人基因组检测。
Science. 2010 Oct 8;330(6001):181-2. doi: 10.1126/science.1194006.
7
Truth in testing laws: a shot in the arm for designer gene tests.检测法律中的真相:对设计基因检测的一针强心剂。
Health Matrix Clevel. 2006 Summer;16(2):797-829.
8
Good gene hunting: commercializing safety and efficacy of home genetic test kits.
J Biolaw Bus. 1999;3(1):29-39.
9
Genetic privacy and the law: an end to genetics exceptionalism.遗传隐私与法律:遗传学例外论的终结
Jurimetrics. 1999 Fall:21-58.
10
The medical examination in United States immigration applications: the potential use of genetic testing leads to heightened privacy concerns.美国移民申请中的体检:基因检测的潜在用途引发了对隐私的高度关注。
J Biolaw Bus. 2005;8(4):22-32.

引用本文的文献

1
Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations.遗传数据和电子健康记录:伦理、后勤和技术考虑因素的讨论。
J Am Med Inform Assoc. 2014 Jan-Feb;21(1):171-80. doi: 10.1136/amiajnl-2013-001694. Epub 2013 Jun 14.